• Most Popular
  • Most Shared

Daiichi says US FDA approves combo hypertension pill

Thu Sep 27, 2007 12:01pm EDT

Stocks

   

WASHINGTON, Sept 27 (Reuters) - Japanese drugmaker Daiichi Sankyo (4568.T) said on Thursday the U.S. Food and Drug Administration approved its new pill for high blood pressure, which combines ingredients from two drugs already on the market.

The pill, which will be promoted in the U.S. with the help of U.S. drugmaker Forest Laboratories Inc (FRX.N), is called Azor and combines chemicals from Daiichi's Benicar and Pfizer Inc's Norvasc, the Japanese company said.



More from Reuters

Photo

Obama reaches climate deal with emerging powers

COPENHAGEN (Reuters) - President Barack Obama forged a climate deal with emerging economic powers on Friday, breaking a deadlock at U.N.-led talks, but said the world still had "much further to go" in the fight against global warming. | Video

» More Top News
A woman shops at a Sam's Club store, a division of Wal-Mart Stores, in Bentonville, Arkansas June 4, 2009. REUTERS/Jessica Rinaldi

The food-stamp economy

On the last day of every month, shoppers at Walmart load their carts with food and household items and wait for the midnight hour. Is this the new normal in America?  Full Article 

U.S.
Two men shake hands in a file photo. REUTERS/File

Let's make a deal

The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis.  Full Article 

Global Deals Review